Real-Time PCR, Digital PCR And End-Point PCR Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2225

The Business Research Company offers in-depth market insights through Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The real-time pcr, digital pcr and end-point pcr market size has grown strongly in recent years. It will grow from $35.11 billion in 2023 to $38.37 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to standardization of pcr protocols, role in personalized medicine, contribution to drug discovery and development, adoption in forensic and paternity testing..

The real-time pcr, digital pcr and end-point pcr market size is expected to see strong growth in the next few years. It will grow to $54.95 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to expansion of molecular diagnostics, growth in infectious disease testing, increasing demand for genetic testing, market penetration in research and forensics, rapid point-of-care pcr solutions.. Major trends in the forecast period include emergence of digital assays, multiplex pcr advancements, shift towards digital pcr technology, automation and high-throughput systems, miniaturization of pcr platforms..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp

Market Segmentation:
The real-time pcr, digital pcr and end-point pcr market covered in this report is segmented -
1) By Product: Instruments, Consumables And Reagents, Software And Services
2) By Technology: Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital
3) By Applications: Clinical, Research, Forensic, Other Applications
4) By End User: Hospital, Diagnostic Labs, Pharma, Biotech, Contract Research Organizations

Major Driver - Elevated Prevalence Of Infectious Diseases Fueling Growth In The Real-Time Pcr, Digital Pcr, And End-Point Pcr Market
The increase in the incidence of infectious diseases is expected to propel the growth of the real-time PCR, digital PCR, and end-point PCR markets going forward. Infectious diseases refer to illnesses caused by the invasion and multiplication of pathogenic microorganisms, including bacteria, viruses, fungi, and parasites. Real-time PCR, digital PCR, and end-point PCR are utilized in infectious diseases to quantify specific pathogens or their genetic material, monitor disease progression, and rapidly diagnose infections such as HIV, hepatitis, respiratory viruses, and tuberculosis. For instance, in July 2023, according to UNAIDS, the Switzerland-based UN program dedicated to addressing the global HIV/AIDS epidemic, the global population living with HIV increased to 39 million in 2022, up 3.17% from 37.7 million in 2020. Moreover, there were approximately 1.3 million new HIV infections reported in 2022. Furthermore, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health organization, in the United States, 8,300 cases of tuberculosis (TB) were reported in 2022, a rise from 7,874 cases in 2021. Therefore, the increase in the incidence of infectious diseases will drive the growth of the cephalosporin market.

Competitive Landscape:
Major companies operating in the real-time pcr, digital pcr and end-point pcr market report are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., GE HealthCare Technologies Inc., Agilent Technologies Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc. , Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG , Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/real-time-pcr-digital-pcr-and-end-point-pcr-global-market-report

Top Trend - Innovative Advances In Digital Pcr Technology Transforming The Real-Time Pcr Market
Major companies operating in the real-time PCR, digital PCR, and end-point PCR markets are developing innovative products using advanced technologies such as digital polymerase chain reaction (dPCR) technology to better understand the nature of a patient's cancer, genetic disease, or infection. Digital polymerase chain reaction (dPCR) technology is a biotechnological refinement of conventional polymerase chain reaction (PCR) methods that can directly quantify and clonally amplify nucleic acid strands, including DNA, cDNA, or RNA. For instance, in August 2022, Roche Diagnostics, a US-based manufacturer of medicines and medical devices, launched the next-generation digital PCR Digital LightCycler System for early detection and treatment of various chronic and genetic disorders. The system is designed to automate workflow and manage data, eliminating the need for external calculations, software, and processors. A combination of three nano well plate configurations, six advanced optical channels, and 5x concentrated DNA and RNA master mixes provides high sensitivity and precision. The Digital LightCycler System is a valuable addition to Roche's portfolio of diagnostic platforms, providing advanced technology, clinical applications, customization and flexibility, and workflow automation.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Real-Time PCR, Digital PCR And End-Point PCR Market Characteristics
3. Real-Time PCR, Digital PCR And End-Point PCR Market Trends And Strategies
4. Real-Time PCR, Digital PCR And End-Point PCR Market - Macro Economic Scenario
5. Real-Time PCR, Digital PCR And End-Point PCR Market Size And Growth
…..
27. Real-Time PCR, Digital PCR And End-Point PCR Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.